BioCentury
ARTICLE | Company News

Management tracks

June 9, 2017 12:30 AM UTC

Neurological diseases play Flex Pharma Inc. (NASDAQ:FLKS) said Christoph Westphal will step down as CEO, effective July 3. He will remain chairman. President of R&D William McVicar will be interim CEO.

Cancer company ViraTherapeutics GmbH (Innsbruck, Austria) named Heinz Schwer CEO. He was CEO of Lanthio Pharma B.V., which MorphoSys AG (Xetra:MOR; Pink:MPSYY) acquired...